| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.6M | -51.2% |
| R&D Expense | $107.8M | -20.1% |
| SG&A Expense | $46.5M | -37.3% |
| Operating Income | -$147.7M | +29.8% |
| Income Tax | $2K | — |
| Net Income | -$136.3M | +26.8% |
| EPS (Basic) | -$1.15 | +29.9% |
| EPS (Diluted) | -$1.15 | +29.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.6M | +29.3% |
| Short-term Investments | $157.0M | -35.4% |
| Accounts Receivable | $916K | -74.1% |
| Current Assets | $208.7M | -28.5% |
| Total Assets | $318.9M | -27.6% |
| Current Liabilities | $36.1M | -6.4% |
| Stockholders' Equity | $207.2M | -35.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$106.1M | +13.7% |
| Capital Expenditures | $6.0M | +715.5% |
| Investing Cash Flow | $111.2M | +809.9% |
| Financing Cash Flow | $5.5M | -94.5% |
| Free Cash Flow | -$112.0M | +9.4% |